Nishio, Naomi <br/><br/>
GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance.  [electronic resource] 

 -  Scientific reports  Aug 2015 
 - 13519 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep13519  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipogenesis--drug effects<br/>Aging--pathology<br/>Animals<br/>Body Weight--drug effects<br/>CHO Cells<br/>Carcinoma, Hepatocellular--complications<br/>Cricetinae<br/>Cricetulus<br/>Diet, High-Fat<br/>Fatty Liver--complications<br/>Insulin--metabolism<br/>Insulin Resistance<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Liver--drug effects<br/>Liver Neoplasms--complications<br/>Male<br/>Mice<br/>Non-alcoholic Fatty Liver Disease--complications<br/>Obesity--complications<br/>Palmitic Acid--pharmacology<br/>Phosphorylation--drug effects<br/>Protein Phosphatase 1--deficiency<br/>Signal Transduction--drug effects